Medicamen Biotech is a finished-dose manufacturer based in India. It appears in 620 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), EFDA (ET) and MINSA (CR). Its GMP standing is certified by ANVISA (Brazil), EMA and NAFDAC (NG), among 4 authorities. Customs aggregates show $12.9M of exports covering 524 molecules to 32 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Haridwar, India | 3016979924 |
| ALWAR, India | Not on file |
| Bhiwadi, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 554 | None |
| EFDA (ET) | 36 | None |
| MINSA (CR) | 10 | None |
| ARCSA (EC) | 8 | None |
| MCAZ (ZW) | 5 | None |
| TMDA (TZ) | 3 | None |
| ANVISA (Brazil) | None | 2 |
| EMA | None | 1 |
| NAFDAC (NG) | None | 1 |
| FDA (GH) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $2.2M | 15 |
| 2025 | Not reported | $12.9M | 32 |
| 2024 | Not reported | $9.7M | 34 |
| 2023 | Not reported | $14.8M | 31 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Medicamen Biotech comes back tiered against every other supplier able to file there.
Start for free